Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;17(1):18-30.

Vaccination of Patients With Inflammatory Bowel Disease During the COVID-19 Pandemic

Sheena Crosby  1 , Michael J Schuh  1 , Freddy Caldera  2 , Francis A Farraye  3
Affiliations

Vaccination of Patients With Inflammatory Bowel Disease During the COVID-19 Pandemic

Sheena Crosby et al. Gastroenterol Hepatol (N Y). 2021 Jan.

Abstract

Inflammatory bowel disease and the subsequent immunosuppressive regimens used to treat this condition increase the risk for acquiring viral and bacterial infections. Ensuring that patients are up-to-date with their immunizations may help prevent the development of several of these vaccine-preventable diseases. Therefore, it is imperative that gastroenterology providers offer vaccinations to patients or direct vaccination guidance to primary care providers to minimize the risk for vaccine-preventable diseases. To decrease the risk for co-infection in the setting of the coronavirus disease 2019 pandemic and avoid placing any further burden on the health care system, the call to immunize is more important than ever.

Keywords: COVID-19; Crohn’s disease; Vaccines; inflammatory bowel disease; preventive care; ulcerative colitis.

PubMed Disclaimer

Conflict of interest statement

Dr Crosby and Dr Schuh have no relevant conflicts of interest to disclose. Dr Caldera has received research support from Takeda Pharmaceuticals and Sanofi. In addition, he has been a consultant for Takeda, Arena Pharmaceuticals, GSK, and Celgene. Dr Farraye has served on advisory boards for Bristol-Myers Squibb, Braintree Laboratories, Gilead, GSK, Innovation Pharmaceuticals, Janssen, Pfizer, and Sebela Pharmaceuticals. He is also a data safety monitoring board member for Lilly and Theravance Biopharma.

Figures

Figure.
Figure.
Recommended pneumococcal vaccination regimens for patients with IBD. Adapted from Caldera F et al. IBD, inflammatory bowel disease; PCV13, 13-valent pneumococcal conjugate vaccine; PPSV23, 23-valent pneumococcal polysaccharide vaccine.
See this image and copyright information in PMC

References

    1. Singh S, Facciorusso A, Dulai PS, Jairath V, Sandborn WJ. Comparative risk of serious infections with biologic and/or immunosuppressive therapy in patients with inflammatory bowel diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2020;18(1):69–81.e3.. - PMC - PubMed
    1. Long MD, Martin C, Sandler RS, Kappelman MD. Increased risk of pneumonia among patients with inflammatory bowel disease. Am J Gastroenterol. 2013;108(2):240–248. - PMC - PubMed
    1. Long MD, Martin C, Sandler RS, Kappelman MD. Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2013;37(4):420–429. - PMC - PubMed
    1. Farraye FA, Melmed GY, Lichtenstein GR, Kane SV. ACG Clinical Guideline: preventive care in inflammatory bowel disease. Am J Gastroenterol. 2017;112(2):241–258. - PubMed
    1. Caldera F, Hayney MS, Farraye FA. Vaccination in patients with inflammatory bowel disease. Am J Gastroenterol. 2020;115(9):1356–1361. - PubMed

LinkOut - more resources